Advertisement

NOV 08, 2023

Medicare’s First 10 Negotiable Drugs, Chatbots in Your Practice?

In This Episode

Digital health expert Patty Riskind (CEO, Orbita) digs into three main barriers physicians may perceive in incorporating chatbots into their practice. Virtual assistants, such as chatbots, have changed the way businesses operate, and how people navigate their day-to-day tasks. From making travel plans to scheduling car services, digital tools are improving consumer access while conserving staff resources, but the medical world has been falling behind.

Also, Marc Bonaca, MD, MPH (University of Colorado), discusses the first 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. A critical step in the Biden administration’s attempt to drive down the high cost of prescription drugs for older people. While Medicare wields enormous power over the costs of other aspects of medical care, dictating how much doctors and hospitals can be paid for medical services, it has been barred from negotiating drug costs. That will change next year, when Medicare for the first time will be able to directly haggle with drug-makers over prices for the costliest medications. The negotiated prices will go into effect in 2026.

Enjoy listening!

Let us know what you thought of this week’s episode on Twitter: @physicianswkly

Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!

Thanks for listening!

Patty Riskind

CEO
Orbita

Marc Bonaca

Executive Director, CPC Clinical Research
Associate Professor, Division of Cardiology
Director of Vascular Research
William R. Hiatt Endowed Chair in Cardiovascular Research
University of Colorado

Rachel Giles, MD, PhD

Medicom Medical Publishers

Advertisement

CONTENT CONTINUES BELOW

Patty Riskind

CEO
Orbita

Marc Bonaca, MD, MPH

Executive Director, CPC Clinical Research
Associate Professor, Division of Cardiology
Director of Vascular Research
William R. Hiatt Endowed Chair in Cardiovascular Research
University of Colorado

Rachel Giles, MD, PhD

Medicom Medical Publishers

Advertisement
Advertisement

Author